The role of vitamin D in blood pressure, endothelial and renal function in postmenopausal women

Nutrients

Volumn 5, Issue 7, 2013, Pages 2590-2610

  Liu, Zhao Min ^a   Woo, Jean ^a   Wu, Sheng Hui ^b   Ho, Suzanne C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Endothelial function; Renal function; Vitamin D

Indexed keywords

CALCIUM; PLACEBO; VITAMIN D;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; NONHUMAN; NUTRITIONAL STATUS; POSTMENOPAUSE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 84880116418     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5072590     Document Type: Review

References (120)

1. Perez-Lopez, F.R.; Chedraui, P.; Fernandez-Alonso, A.M. Vitamin d and aging: Beyond calcium and bone metabolism. Maturitas 2011, 69, 27-36.
2. Duque, G.; El Abdaimi, K.; Macoritto, M.; Miller, M.M.; Kremer, R. Estrogens (e2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: Changes with aging and hormone deprivation. Biochem. Biophys. Res. Commun. 2002, 299, 446-454.
3. Mithal, A.; Wahl, D.A.; Bonjour, J.P.; Burckhardt, P.; Dawson-Hughes, B.; Eisman, J.A.; El-Hajj Fuleihan, G.; Josse, R.G.; Lips, P.; Morales-Torres, J. Global vitamin D status and determinants of hypovitaminosis d. Osteoporos. Int. 2009, 20, 1807-1820.
4. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
5. Sai, A.J.; Walters, R.W.; Fang, X.; Gallagher, J.C. Relationship between vitamin D, parathyroid hormone, and bone health. J. Clin. Endocrinol. Metab. 2011, 96, E436-E446.
6. Howe, W.R.; Dellavalle, R. Vitamin D deficiency. N. Engl. J. Med. 2007, 357,266-281.
7. Gaugris, S.; Heaney, R.P.; Boonen, S.; Kurth, H.; Bentkover, J.D.; Sen, S.S. Vitamin D inadequacy among post-menopausal women: A systematic review. Q. J. Med. 2005, 98, 667-676.
8. Wat, W.Z.; Leung, J.Y.; Tam, S.; Kung, A.W. Prevalence and impact of vitamin D insufficiency in southern chinese adults. Ann. Nutr. Metab. 2007, 51, 59-64.
9. Lim, S.K.; Kung, A.W.; Sompongse, S.; Soontrapa, S.; Tsai, K.S. Vitamin D inadequacy in postmenopausal women in Eastern Asia. Curr. Med. Res. Opin. 2008, 24, 99-106.
10. Kung, A.W.; Lee, K.K. Knowledge of vitamin d and perceptions and attitudes toward sunlight among chinese middle-aged and elderly women: A population survey in hong kong. BMC Public Health 2006, 6, 226.
11. Lips, P.; Duong, T.; Oleksik, A.; Black, D.; Cummings, S.; Cox, D.; Nickelsen, T. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J. Clin. Endocrinol. Metab. 2001, 86, 1212-1221.
12. Baz-Hecht, M.; Goldfine, A.B. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17, 113-119.
13. Dawson-Hughes, B.; Mithal, A.; Bonjour, J.P.; Boonen, S.; Burckhardt, P.; Fuleihan, G.E.; Josse, R.G.; Lips, P.; Morales-Torres, J.; Yoshimura, N. Iof position statement: Vitamin D recommendations for older adults. Osteoporos. Int. 2010, 21, 1151-1154.
14. Ross, A.C.; Manson, J.E.; Abrams, S.A.; Aloia, J.F.; Brannon, P.M.; Clinton, S.K.; Durazo-Arvizu, R.A.; Gallagher, J.C.; Gallo, R.L.; Jones, G.; et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: What clinicians need to know. J. Clin. Endocrinol. Metab. 2011, 96, 53-58.
15. Dawson-Hughes, B.; Heaney, R.P.; Holick, M.F.; Lips, P.; Meunier, P.J.; Vieth, R. Estimates of optimal vitamin D status. Osteoporos. Int. 2005, 16, 713-716.
16. Carter, G.D.; Carter, R.; Jones, J.; Berry, J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin. Chem. 2004, 50, 2195-2197.
17. Zerwekh, J.E. Blood biomarkers of vitamin d status. Am. J. Clin. Nutr. 2008, 87, 1087S-1091S.
18. Calvo, M.S.; Whiting, S.J.; Barton, C.N. Vitamin D fortification in the united states and canada: Current status and data needs. Am. J. Clin. Nutr. 2004, 80, 1710S-1716S.
19. Dusso, A.S.; Brown, A.J.; Slatopolsky, E. Vitamin D. Am. J. Physiol. Ren. Physiol. 2005, 289, F8-F28.
20. Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80, 1678S-1688S.
21. Wolpowitz, D.; Gilchrest, B.A. The vitamin D questions: How much do you need and how should you get it? J. Am. Acad. Dermatol. 2006, 54, 301-317.
22. Chel, V.; Wijnhoven, H.A.; Smit, J.H.; Ooms, M.; Lips, P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos. Int. 2008, 19, 663-671.
23. Wu, F.; Staykova, T.; Horne, A.; Clearwater, J.; Ames, R.; Mason, B.; Orr-Walker, B.; Gamble, G.; Scott, M.; Reid, I. Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N. Z. Med. J. 2003, 116, U536.
24. DeLuca, H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80, 1689S-1696S.
25. Heaney, R.P. The vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol. 2005, 97, 13-19.
26. Merke, J.; Milde, P.; Lewicka, S.; Hugel, U.; Klaus, G.; Mangelsdorf, D.J.; Haussler, M.R.; Rauterberg, E.W.; Ritz, E. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J. Clin. Investig. 1989, 83, 1903-1915.
27. Merke, J.; Hofmann, W.; Goldschmidt, D.; Ritz, E. Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif. Tissue Int. 1987, 41, 112-114.
28. Somjen, D.; Weisman, Y.; Kohen, F.; Gayer, B.; Limor, R.; Sharon, O.; Jaccard, N.; Knoll, E.; Stern, N. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111, 1666-1671.
29. Wu-Wong, J.R. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br. J. Pharmacol. 2009, 158, 395-412.
30. Zittermann, A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog. Biophys. Mol. Biol. 2006, 92, 39-48.
31. Hagenau, T.; Vest, R.; Gissel, T.N.; Poulsen, C.S.; Erlandsen, M.; Mosekilde, L.; Vestergaard, P. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: An ecologic meta-regression analysis. Osteoporos. Int. 2009, 20, 133-140.
32. Ginde, A.A.; Liu, M.C.; Camargo, C.A., Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med. 2009, 169, 626-632.
33. Godar, D.E.; Landry, R.J.; Lucas, A.D. Increased uva exposures and decreased cutaneous vitamin D3 levels may be responsible for the increasing incidence of melanoma. Med. Hypotheses 2009, 72, 434-443.
34. Zittermann, A.; Schleithoff, S.S.; Koerfer, R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 2005, 94, 483-492.
35. Tangpricha, V.; Koutkia, P.; Rieke, S.M.; Chen, T.C.; Perez, A.A.; Holick, M.F. Fortification of orange juice with vitamin D: A novel approach for enhancing vitamin D nutritional health. Am. J. Clin. Nutr. 2003, 77, 1478-1483.
36. Holick, M.F.; Biancuzzo, R.M.; Chen, T.C.; Klein, E.K.; Young, A.; Bibuld, D.; Reitz, R.; Salameh, W.; Ameri, A.; Tannenbaum, A.D. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 2008, 93, 677-681.
37. Bacon, C.J. High-Dose Vitamin D Supplementation in the Elderly. In Handbook of Vitamin D in Human Health; Watson, R.R., Ed.; Wageningen Academic Publishers: Wageningen, the Netherlands, 2013.
38. Melamed, M.L.; Michos, E.D.; Post, W.; Astor, B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 2008, 168, 1629-1637.
39. Cannell, J.J.; Hollis, B.W. Use of vitamin D in clinical practice. Altern. Med. Rev. 2008, 13, 6-20.
40. Bischoff-Ferrari, H.A.; Giovannucci, E.; Willett, W.C.; Dietrich, T.; Dawson-Hughes, B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84, 18-28.
41. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911-1930.
42. Li, Y.C.; Kong, J.; Wei, M.; Chen, Z.F.; Liu, S.Q.; Cao, L.P. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Investig. 2002, 110, 229-238.
43. Pilz, S.; Tomaschitz, A.; Ritz, E.; Pieber, T.R. Vitamin D status and arterial hypertension: A systematic review. Nat. Rev. Cardiol. 2009, 6, 621-630.
44. Rammos, G.; Tseke, P.; Ziakka, S. Vitamin D, the renin-angiotensin system, and insulin resistance. Int. Urol. Nephrol. 2008, 40, 419-426.
45. Scragg, R.; Sowers, M.; Bell, C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am. J. Hypertens. 2007, 20, 713-719.
46. Judd, S.E.; Nanes, M.S.; Ziegler, T.R.; Wilson, P.W.; Tangpricha, V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white americans: Results from the third national health and nutrition examination survey. Am. J. Clin. Nutr. 2008, 87, 136-141.
47. Martins, D.; Wolf, M.; Pan, D.; Zadshir, A.; Tareen, N.; Thadhani, R.; Felsenfeld, A.; Levine, B.; Mehrotra, R.; Norris, K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the united states: Data from the third national health and nutrition examination survey. Arch. Intern. Med. 2007, 167, 1159-1165.
48. Hintzpeter, B.; Mensink, G.B.; Thierfelder, W.; Muller, M.J.; Scheidt-Nave, C. Vitamin D status and health correlates among german adults. Eur. J. Clin. Nutr. 2008, 62, 1079-1089.
49. Hypponen, E.; Boucher, B.J.; Berry, D.J.; Power, C. 25-hydroxyvitamin d, igf-1, and metabolic syndrome at 45 years of age: A cross-sectional study in the 1958 british birth cohort. Diabetes 2008, 57, 298-305.
50. Forouhi, N.G.; Luan, J.; Cooper, A.; Boucher, B.J.; Wareham, N.J. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The medical research council ely prospective study 1990-2000. Diabetes 2008, 57, 2619-2625.
51. Reis, J.P.; von Muhlen, D.; Kritz-Silverstein, D.; Wingard, D.L.; Barrett-Connor, E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007, 30, 1549-1555.
52. Gannage-Yared, M.H.; Chedid, R.; Khalife, S.; Azzi, E.; Zoghbi, F.; Halaby, G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur. J. Endocrinol. 2009, 160, 965-971.
53. Pasco, J.A.; Henry, M.J.; Nicholson, G.C.; Brennan, S.L.; Kotowicz, M.A. Behavioural and physical characteristics associated with vitamin D status in women. Bone 2009, 44, 1085-1091.
54. Rueda, S.; Fernandez-Fernandez, C.; Romero, F.; Martinez de Osaba, J.; Vidal, J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes. Surg. 2008, 18, 151-154.
55. Chan, R.; Chan, D.; Woo, J.; Ohlsson, C.; Mellstrom, D.; Kwok, T.; Leung, P. Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older chinese men. J. Hum. Hypertens. 2012, 26, 20-27.
56. Williams, D.M.; Fraser, A.; Lawlor, D.A. Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart 2011, 97, 315-320.
57. Dorjgochoo, T.; Shu, X.O.; Xiang, Y.B.; Yang, G.; Cai, Q.; Li, H.; Ji, B.T.; Cai, H.; Gao, Y.T.; Zheng, W. Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the shanghai women's and men's health studies. Br. J. Nutr. 2012, 108, 449-458.
58. Snijder, M.B.; Lips, P.; Seidell, J.C.; Visser, M.; Deeg, D.J.; Dekker, J.M.; van Dam, R.M. Vitamin D status and parathyroid hormone levels in relation to blood pressure: A population-based study in older men and women. J. Intern. Med. 2007, 261, 558-565.
59. Bolland, M.J.; Bacon, C.J.; Horne, A.M.; Mason, B.H.; Ames, R.W.; Wang, T.K.; Grey, A.B.; Gamble, G.D.; Reid, I.R. Vitamin D insufficiency and health outcomes over 5 year in older women. Am. J. Clin. Nutr. 2010, 91, 82-89.
60. Margolis, K.L.; Martin, L.W.; Ray, R.M.; Kerby, T.J.; Allison, M.A.; Curb, J.D.; Kotchen, T.A.; Liu, S.; Wassertheil-Smoller, S.; Manson, J.E. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am. J. Epidemiol. 2012, 175, 22-32.
61. Wang, T.J.; Pencina, M.J.; Booth, S.L.; Jacques, P.F.; Ingelsson, E.; Lanier, K.; Benjamin, E.J.; D'Agostino, R.B.; Wolf, M.; Vasan, R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117, 503-511.
62. Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49, 1063-1069.
63. Margolis, K.L.; Ray, R.M.; van Horn, L.; Manson, J.E.; Allison, M.A.; Black, H.R.; Beresford, S.A.; Connelly, S.A.; Curb, J.D.; Grimm, R.H., Jr.; et al. Effect of calcium and vitamin D supplementation on blood pressure: The women's health initiative randomized trial. Hypertension 2008, 52, 847-855.
64. Wood, A.D.; Secombes, K.R.; Thies, F.; Aucott, L.; Black, A.J.; Mavroeidi, A.; Simpson, W.G.; Fraser, W.D.; Reid, D.M.; Macdonald, H.M. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: A parallel-group, double-blind, placebo-controlled RCT. J. Clin. Endocrinol. Metab. 2012, 97, 3557-3568.
65. Pfeifer, M.; Begerow, B.; Minne, H.W.; Nachtigall, D.; Hansen, C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 2001, 86, 1633-1637.
66. Sugden, J.A.; Davies, J.I.; Witham, M.D.; Morris, A.D.; Struthers, A.D. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet. Med. 2008, 25, 320-325.
67. Witham, M.D.; Nadir, M.A.; Struthers, A.D. Effect of vitamin d on blood pressure: A systematic review and meta-analysis. J. Hypertens. 2009, 27, 1948-1954.
68. Widlansky, M.E.; Gokce, N.; Keaney, J.F., Jr.; Vita, J.A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 2003, 42, 1149-1160.
69. Nadar, S.; Blann, A.D.; Lip, G.Y. Endothelial dysfunction: Methods of assessment and application to hypertension. Curr. Pharm. Des. 2004, 10, 3591-3605.
70. Endemann, D.H.; Schiffrin, E.L. Endothelial dysfunction. J. Am. Soc. Nephrol. 2004, 15, 1983-1992.
71. Norman, P.E.; Powell, J.T. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 39-46.
72. Zehnder, D.; Bland, R.; Chana, R.S.; Wheeler, D.C.; Howie, A.J.; Williams, M.C.; Stewart, P.M.; Hewison, M. Synthesis of 1,25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: A novel autocrine determinant of vascular cell adhesion. J. Am. Soc. Nephrol. 2002, 13, 621-629.
73. Molinari, C.; Uberti, F.; Grossini, E.; Vacca, G.; Carda, S.; Invernizzi, M.; Cisari, C. 1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell. Physiol. Biochem. 2011, 27, 661-668.
74. Aihara, K.; Azuma, H.; Akaike, M.; Ikeda, Y.; Yamashita, M.; Sudo, T.; Hayashi, H.; Yamada, Y.; Endoh, F.; Fujimura, M.; et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J. Biol. Chem. 2004, 279, 35798-35802.
75. Urena-Torres, P.; Metzger, M.; Haymann, J.P.; Karras, A.; Boffa, J.J.; Flamant, M.; Vrtovsnik, F.; Gauci, C.; Froissart, M.; Houillier, P.; et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am. J. Kidney Dis. 2011, 58, 544-553.
76. Tarcin, O.; Yavuz, D.G.; Ozben, B.; Telli, A.; Ogunc, A.V.; Yuksel, M.; Toprak, A.; Yazici, D.; Sancak, S.; Deyneli, O.; et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J. Clin. Endocrinol. Metab. 2009, 94, 4023-4030.
77. Jablonski, K.L.; Chonchol, M.; Pierce, G.L.; Walker, A.E.; Seals, D.R. 25-hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011, 57, 63-69.
78. Pilz, S.; Tomaschitz, A.; Drechsler, C.; Ritz, E.; Boehm, B.O.; Grammer, T.B.; Marz, W. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur. Heart J. 2010, 31, 1591-1598.
79. Momiyama, Y.; Ohmori, R.; Tanaka, N.; Kato, R.; Taniguchi, H.; Adachi, T.; Nakamura, H.; Ohsuzu, F. High plasma levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis 2010, 209, 206-210.
80. Yiu, Y.F.; Chan, Y.H.; Yiu, K.H.; Siu, C.W.; Li, S.W.; Wong, L.Y.; Lee, S.W.L.; Tam, S.; Wong, E.W.K.; Cheung, B.M.Y.; et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 2011, 96, E830-E835.
81. Codoner-Franch, P.; Tavarez-Alonso, S.; Simo-Jorda, R.; Laporta-Martin, P.; Carratala-Calvo, A.; Alonso-Iglesias, E. Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J. Pediatr. 2012, 161, 848-854.
82. Stricker, H.; Tosi Bianda, F.; Guidicelli-Nicolosi, S.; Limoni, C.; Colucci, G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: A randomised controlled pilot study. Eur. J. Vasc. Endovasc. Surg. 2012, 44, 307-312.
83. Longenecker, C.T.; Hileman, C.O.; Carman, T.L.; Ross, A.C.; Seydafkan, S.; Brown, T.T.; Labbato, D.E.; Storer, N.; Tangpricha, V.; McComsey, G.A. Vitamin D supplementation and endothelial function in vitamin D deficient hiv-infected patients: A randomized placebo-controlled trial. Antivir. Ther. 2012, 17, 613-621.
84. Gepner, A.D.; Ramamurthy, R.; Krueger, D.C.; Korcarz, C.E.; Binkley, N.; Stein, J.H. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012, 7, e36617.
85. Shab-Bidar, S.; Neyestani, T.R.; Djazayery, A.; Eshraghian, M.R.; Houshiarrad, A.; Gharavi, A.; Kalayi, A.; Shariatzadeh, N.; Zahedirad, M.; Khalaji, N.; et al. Regular consumption of vitamin D-fortified yogurt drink (doogh) improved endothelial biomarkers in subjects with type 2 diabetes: A randomized double-blind clinical trial. BMC Med. 2011, 9, 125.
86. Harris, R.A.; Pedersen-White, J.; Guo, D.H.; Stallmann-Jorgensen, I.S.; Keeton, D.; Huang, Y.; Shah, Y.; Zhu, H.; Dong, Y. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight african-american adults. Am. J. Hypertens. 2011, 24, 557-562.
87. Dong, Y.; Stallmann-Jorgensen, I.S.; Pollock, N.K.; Harris, R.A.; Keeton, D.; Huang, Y.; Li, K.; Bassali, R.; Guo, D.H.; Thomas, J.; et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-Hydroxyvitamin D, adiposity, and arterial stiffness. J. Clin. Endocrinol. Metab. 2010, 95, 4584-4591.
88. Witham, M.D.; Dove, F.J.; Sugden, J.A.; Doney, A.S.; Struthers, A.D. The effect of vitamin D replacement on markers of vascular health in stroke patients-A randomised controlled trial. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 864-870.
89. Schleithoff, S.S.; Zittermann, A.; Tenderich, G.; Berthold, H.K.; Stehle, P.; Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 2006, 83, 754-759.
90. Witham, M.D.; Dove, F.J.; Dryburgh, M.; Sugden, J.A.; Morris, A.D.; Struthers, A.D. The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: A randomised controlled trial. Diabetologia 2010, 53, 2112-2119.
91. Al Mheid, I.; Patel, R.; Murrow, J.; Morris, A.; Rahman, A.; Fike, L.; Kavtaradze, N.; Uphoff, I.; Hooper, C.; Tangpricha, V.; et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J. Am. Coll. Cardiol. 2011, 58, 186-192.
92. Levin, A.; Bakris, G.L.; Molitch, M.; Smulders, M.; Tian, J.; Williams, L.A.; Andress, D.L. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int. 2007, 71, 31-38.
93. Dusso, A.; Gonzalez, E.A.; Martin, K.J. Vitamin d in chronic kidney disease. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25, 647-655.
94. Moe, S.; Drueke, T.; Cunningham, J.; Goodman, W.; Martin, K.; Olgaard, K.; Ott, S.; Sprague, S.; Lameire, N.; Eknoyan, G. Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (kdigo). Kidney Int. 2006, 69, 1945-1953.
95. Andress, D.L. Vitamin D in chronic kidney disease: A systemic role for selective vitamin d receptor activation. Kidney Int. 2006, 69, 33-43.
96. Jacob, A.I.; Sallman, A.; Santiz, Z.; Hollis, B.W. Defective photoproduction of cholecalciferol in normal and uremic humans. J. Nutr. 1984, 114, 1313-1319.
97. Barreto, D.V.; Barreto, F.C.; Liabeuf, S.; Temmar, M.; Boitte, F.; Choukroun, G.; Fournier, A.; Massy, Z.A. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2009, 4, 1128-1135.
98. Inaguma, D.; Nagaya, H.; Hara, K.; Tatematsu, M.; Shinjo, H.; Suzuki, S.; Mishima, T.; Kurata, K. Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin. Exp. Nephrol. 2008, 12, 126-131.
99. Ravani, P.; Malberti, F.; Tripepi, G.; Pecchini, P.; Cutrupi, S.; Pizzini, P.; Mallamaci, F.; Zoccali, C. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009, 75, 88-95.
100. De Boer, I.H.; Ioannou, G.N.; Kestenbaum, B.; Brunzell, J.D.; Weiss, N.S. 25-hydroxyvitamin D levels and albuminuria in the third national health and nutrition examination survey (NHANES iii). Am. J. Kidney Dis. 2007, 50, 69-77.
101. Tentori, F.; Hunt, W.C.; Stidley, C.A.; Rohrscheib, M.R.; Bedrick, E.J.; Meyer, K.B.; Johnson, H.K.; Zager, P.G. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 2006, 70, 1858-1865.
102. Shoben, A.B.; Rudser, K.D.; de Boer, I.H.; Young, B.; Kestenbaum, B. Association of oral calcitriol with improved survival in nondialyzed ckd. J. Am. Soc. Nephrol. 2008, 19, 1613-1619.
103. Wolf, M.; Shah, A.; Gutierrez, O.; Ankers, E.; Monroy, M.; Tamez, H.; Steele, D.; Chang, Y.; Camargo, C.A., Jr.; Tonelli, M.; et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007, 72, 1004-1013.
104. Mirkovic, K.; van den Born, J.; Navis, G.; de Borst, M.H. Vitamin D in chronic kidney disease: New potential for intervention. Curr. Drug Targets 2011, 12, 42-53.
105. Li, Y.C. Vitamin D: Roles in renal and cardiovascular protection. Curr. Opin. Nephrol. Hypertens. 2012, 21, 72-79.
106. Dusso, A.S.; Tokumoto, M. Defective renal maintenance of the vitamin D endocrine system impairs vitamin d renoprotection: A downward spiral in kidney disease. Kidney Int. 2011, 79, 715-729.
107. Gal-Moscovici, A.; Sprague, S.M. Use of vitamin D in chronic kidney disease patients. Kidney Int. 2010, 78, 146-151.
108. Naves-Diaz, M.; Alvarez-Hernandez, D.; Passlick-Deetjen, J.; Guinsburg, A.; Marelli, C.; Rodriguez-Puyol, D.; Cannata-Andia, J.B. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int. 2008, 74, 1070-1078.
109. Teng, M.; Wolf, M.; Lowrie, E.; Ofsthun, N.; Lazarus, J.M.; Thadhani, R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N. Engl. J. Med. 2003, 349, 446-456.
110. Teng, M.; Wolf, M.; Ofsthun, M.N.; Lazarus, J.M.; Hernan, M.A.; Camargo, C.A., Jr.; Thadhani, R. Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J. Am. Soc. Nephrol. 2005, 16, 1115-1125.
111. De Zeeuw, D.; Agarwal, R.; Amdahl, M.; Audhya, P.; Coyne, D.; Garimella, T.; Parving, H.H.; Pritchett, Y.; Remuzzi, G.; Ritz, E.; et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (vital study): A randomised controlled trial. Lancet 2010, 376, 1543-1551.
112. Agarwal, R.; Acharya, M.; Tian, J.; Hippensteel, R.L.; Melnick, J.Z.; Qiu, P.; Williams, L.; Batlle, D. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005, 68, 2823-2828.
113. Alborzi, P.; Patel, N.A.; Peterson, C.; Bills, J.E.; Bekele, D.M.; Bunaye, Z.; Light, R.P.; Agarwal, R. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial. Hypertension 2008, 52, 249-255.
114. Verstuyf, A.; Carmeliet, G.; Bouillon, R.; Mathieu, C. Vitamin D: A pleiotropic hormone. Kidney Int. 2010, 78, 140-145.
115. Jones, G. Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-(OH)-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D3. Semin. Dial. 2007, 20, 316-324.
116. Hathcock, J.N.; Shao, A.; Vieth, R.; Heaney, R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85, 6-18.
117. Ozkan, B.; Hatun, S.; Bereket, A. Vitamin D intoxication. Turk. J. Pediatr. 2012, 54, 93-98.
118. Sanders, K.M.; Stuart, A.L.; Williamson, E.J.; Simpson, J.A.; Kotowicz, M.A.; Young, D.; Nicholson, G.C. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 2010, 303, 1815-1822.
119. Heaney, R.P. Vitamin D-Baseline status and effective dose. N. Engl. J. Med. 2012, 367, 77-78.
120. Grey, A.; Bolland, M. Vitamin D: A place in the sun? Arch. Intern. Med. 2010, 170, 1099-1100.